News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Hidehito Horinouchi: Thank you so much Solange Peters for coming to Japan
Photo taken from: Hidehito Horinouchi/X
Feb 26, 2024, 09:51

Hidehito Horinouchi: Thank you so much Solange Peters for coming to Japan

Hidehito Horinouchi, Medical Oncologist, Assistant Chief in the Department of Thoracic Oncology at National Cancer Center Hospital, Japan, made the following post on X:

“Thank you so much Solange Peters for coming to Japan JSMO2024 while Santa Monica is in the middle of the excitement of TTLC24.”

Source: Hidehito Horinouchi/X

cancer Hidehito Horinouchi OncoDaily Oncology Solange Peters
Special Coverage
Blog
Aug 2, 2025, 11:51
The Benefits and Nuances of Precision Palliative Care - Penn Center for Cancer Care Innovation
Blog
Aug 2, 2025, 11:45
Justine Eaglin Swindell: African Cancer Coalition Awareness Month
Blog
Aug 2, 2025, 11:39
Chemotherapy’s Done - But the Fog Isn’t - City of Hope | Orange County
Insight
Aug 2, 2025, 11:32
Joe Y Chang: Is Systemic LND Always Necessary In Early-Stage NSCLC?
Blog
Aug 2, 2025, 11:26
Douglas Flora: For My Cancer Survivors Out There
Career
Aug 2, 2025, 11:23
Mohamed A Gouda Has Been Appointed Assistant Professor of Medical Oncology at MD Anderson Cancer Center
Radiotherapy
Aug 2, 2025, 11:21
Elekta: Radiotherapy Giant
Blog
Aug 2, 2025, 11:13
ASH Welcomes the Third Cohort of Fellows in the Hematology-Focused Fellowship Training Program
Career
Aug 2, 2025, 11:07
Tilman Krueger Has Been Appointed Director Oncology Policy EU and Pipeline at MSD
Insight
Aug 2, 2025, 11:00
Andres F. Cardona: How Sponsored Clinical Trials Can Generate Economic Value for Healthcare Systems
Blog
Aug 2, 2025, 10:59
Let’s Break the Silence and End Alcohol Harm - Pink Hearts Cancer Support Foundation
Drugs
Aug 2, 2025, 10:49
Emrelis (Telisotuzumab vedotin) Patient Guide 2025: A New Targeted Treatment for Advanced Lung Cancer